Literature DB >> 6180100

Altered pharmacologic properties of liposome-associated human interferon-alpha. II.

D A Eppstein.   

Abstract

Association of human interferon-alpha with multilamellar vesicles and reverse-phase evaporation vesicles resulted in altered retention and distribution of the interferon after injection into mice. Intramuscular injection of liposomal-interferon, after extrusion through 0.2 mu filters, resulted in significantly increased localized retention of interferon. Liposomal-interferon was retained locally from one to three days, depending on liposome composition, whereas an equivalent injection of free interferon was undetectable after 24 hrs. Intravenous injection of the liposomal-interferon preparations resulted in increased interferon levels in lung, spleen, and liver as compared to injection of free interferon. Preparation of small unilamellar vesicles in the presence of interferon revealed differences in modes of association of different species with the liposomes, based on differential titers on human vs. bovine cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6180100     DOI: 10.1089/jir.1982.2.117

Source DB:  PubMed          Journal:  J Interferon Res        ISSN: 0197-8357


  6 in total

1.  Topical delivery of liposomally encapsulated interferon evaluated in a cutaneous herpes guinea pig model.

Authors:  N Weiner; N Williams; G Birch; C Ramachandran; C Shipman; G Flynn
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

2.  Interferon gamma encapsulated into liposomes enhances the activity of monocytes and natural killer cells and has antiproliferative effects on tumor cells in vitro.

Authors:  I Rutenfranz; A Bauer; H Kirchner
Journal:  Blut       Date:  1990-07

3.  Pharmacokinetics of an extended-release human interferon alpha-2b formulation.

Authors:  A Bonetti; S Kim
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

Review 4.  Particle-mediated delivery of cytokines for immunotherapy.

Authors:  David A Christian; Christopher A Hunter
Journal:  Immunotherapy       Date:  2012-04       Impact factor: 4.196

Review 5.  Liposomes as carriers of cancer chemotherapy. Current status and future prospects.

Authors:  S Kim
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

6.  Biological activity of liposome-encapsulated murine interferon gamma is mediated by a cell membrane receptor.

Authors:  D A Eppstein; Y V Marsh; M van der Pas; P L Felgner; A B Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.